Literature DB >> 12776221

Neurotrophic factors as novel therapeutics for neuropathic pain.

Dinah W Y Sah1, Michael H Ossipo, Frank Porreca.   

Abstract

Neuropathic pain is a chronic condition that is caused by injury to the nervous system. Unlike acute pain, which is protective, neuropathic pain persists and serves no useful purpose, and severely affects quality of life. However, present therapies have modest efficacy in most patients, are palliative rather than curative, and their side effects represent significant limitations. Tremendous progress has been made over the past decade in our understanding of the biology of pain sensory neurons. The recent discovery that neurotrophic factors play an important role in neuropathic pain indicates that these pathways could serve as novel intervention points for therapy. Moreover, neurotrophic factors have the potential to address the underlying pathophysiology of neuropathic pain, thereby halting or reversing the disease process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776221     DOI: 10.1038/nrd1107

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  37 in total

1.  TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury.

Authors:  Koichi Obata; Hirokazu Katsura; Toshiyuki Mizushima; Hiroki Yamanaka; Kimiko Kobayashi; Yi Dai; Tetsuo Fukuoka; Atsushi Tokunaga; Makoto Tominaga; Koichi Noguchi
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

Review 2.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

3.  Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury.

Authors:  Ruizhong Wang; Tamara King; Michael H Ossipov; Anthony J Rossomando; Todd W Vanderah; Pamela Harvey; Peter Cariani; Eric Frank; Dinah W Y Sah; Frank Porreca
Journal:  Nat Neurosci       Date:  2008-03-23       Impact factor: 24.884

Review 4.  Growth factors and neuropathic pain.

Authors:  Michael H Ossipov
Journal:  Curr Pain Headache Rep       Date:  2011-06

5.  Herpes zoster chronification to postherpetic neuralgia induces brain activity and grey matter volume change.

Authors:  Song Cao; Bangyong Qin; Yi Zhang; Jie Yuan; Bao Fu; Peng Xie; Ganjun Song; Ying Li; Tian Yu
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

6.  Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy.

Authors:  P Y Geha; M N Baliki; D R Chialvo; R N Harden; J A Paice; A V Apkarian
Journal:  Pain       Date:  2006-10-25       Impact factor: 6.961

7.  Development of an Experimental Animal Model for Lower Back Pain by Percutaneous Injury-Induced Lumbar Facet Joint Osteoarthritis.

Authors:  Jae-Sung Kim; Kasra Ahmadinia; Xin Li; John L Hamilton; Steven Andrews; Chris A Haralampus; Guozhi Xiao; Hong-Moon Sohn; Jae-Won You; Yo-Seob Seo; Gary S Stein; Andre J Van Wijnen; Su-Gwan Kim; Hee-Jeong Im
Journal:  J Cell Physiol       Date:  2015-11       Impact factor: 6.384

Review 8.  Research progress of the role and mechanism of extracellular signal-regulated protein kinase 5 (ERK5) pathway in pathological pain.

Authors:  Li-Na Yu; Li-Hong Sun; Min Wang; Min Yan
Journal:  J Zhejiang Univ Sci B       Date:  2016 Oct.       Impact factor: 3.066

9.  The regulation of sGC on the rat model of neuropathic pain is mediated by 5-HT1ARs and NO/cGMP pathway.

Authors:  Zifeng Xu; Bin Yang; Jianhai Zhang; Jijian Zheng
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 10.  Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain.

Authors:  Thierry Bordet; Rebecca M Pruss
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.